UBS Raises Price Target on Dentsply Int'l (XRAY) Following 1Q and Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Dentsply Int'l (XRAY) Tops Q1 EPS by 7c
May 6, 2016 6:07 AM EDTDentsply Int'l (NASDAQ: XRAY) reported Q1 EPS of $0.70, $0.07 better than the analyst estimate of $0.63. Revenue for the quarter came in at $772.6 million versus the consensus estimate of $741.8 million.
GUIDANCE:
Dentsply Int'l sees FY2016 EPS of $2.70-$2.80, versus the consensus of... More
